Portfolio Holdings Detail for ISIN IE000T9EOCL3
Stock Name / Fund iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)
Issuer
Entity holding fund iShares III Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker EWSA(USD) Euronext Amsterdam

Holdings detail for DNA

Stock Name	Ginkgo Bioworks Holdings
Ticker	DNA(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US37611X1000

Show aggregate DNA holdings

News associated with DNA

Ginkgo Bioworks (NYSE:DNA) Price Target Raised to $9.00: Ginkgo Bioworks (NYSE:DNA – Free Report) had its target price lifted by BTIG Research from $6.00 to $9.00 in a report issued on Monday morning,Benzinga reports. The firm currently has a sell rating on the stock. Separately, Cowen restated a “buy” rating on shares of Ginkgo Bioworks in a research report on Friday, August 8th. […] - 2025-08-26 02:54:46
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 63.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 311,846 shares of the company’s stock after purchasing an additional 120,572 shares during the quarter. Exchange […] - 2025-06-18 05:18:50
Squarepoint Ops LLC Sells 60,696 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): Squarepoint Ops LLC reduced its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 58.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 42,490 shares of the company’s stock after selling 60,696 shares during the period. Squarepoint Ops LLC’s holdings in Ginkgo Bioworks were worth $417,000 as of its […] - 2025-06-06 05:14:56
Millennium Management LLC Buys 523,571 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): Millennium Management LLC increased its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 357.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 670,065 shares of the company’s stock after acquiring an additional 523,571 shares during the quarter. Millennium Management LLC’s holdings in Ginkgo Bioworks were worth $6,580,000 at […] - 2025-05-28 04:56:51
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Bank of America Corp DE: Bank of America Corp DE grew its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 780.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,764,455 shares of the company’s stock after acquiring an additional 3,336,964 shares during the period. Bank of […] - 2025-05-16 06:03:08
BNP Paribas Financial Markets Increases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): BNP Paribas Financial Markets raised its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 80.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 285,111 shares of the company’s stock after buying an additional 127,249 shares during […] - 2025-05-16 05:24:57
Tower Research Capital LLC TRC Has $167,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): Tower Research Capital LLC TRC lessened its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 16,972 shares of the company’s stock after selling 3,899 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Ginkgo Bioworks were worth $167,000 […] - 2025-05-07 05:32:53
Ginkgo Bioworks (NYSE:DNA) versus Palisade Bio (NASDAQ:PALI) Financial Contrast: Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Palisade Bio (NASDAQ:PALI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a breakdown of […] - 2025-05-07 03:08:50
Marshall Wace LLP Makes New $665,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): Marshall Wace LLP purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 67,684 shares of the company’s stock, valued at approximately $665,000. Marshall Wace LLP owned approximately 0.12% of Ginkgo […] - 2025-05-02 05:32:47
SBI Securities Co. Ltd. Purchases Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA): SBI Securities Co. Ltd. purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,905 shares of the company’s stock, valued at approximately $29,000. Other institutional investors have also […] - 2025-03-13 06:02:49

iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) DNA holdings

Date	Number of DNA Shares Held	Base Market Value of DNA Shares	Local Market Value of DNA Shares	Change in DNA Shares Held	Change in DNA Base Value	Current Price per DNA Share Held	Previous Price per DNA Share Held
2025-12-02 (Tuesday)	586	USD 5,034	USD 5,034
2025-12-01 (Monday)	586	USD 5,069	USD 5,069	0	USD -369	USD 8.65017	USD 9.27986
2025-11-28 (Friday)	586	USD 5,438	USD 5,438	0	USD 100	USD 9.27986	USD 9.10921
2025-11-27 (Thursday)	586	USD 5,338	USD 5,338	0	USD 0	USD 9.10921	USD 9.10921
2025-11-26 (Wednesday)	586	USD 5,338	USD 5,338	0	USD 234	USD 9.10921	USD 8.7099
2025-11-25 (Tuesday)	586	USD 5,104	USD 5,104	0	USD 59	USD 8.7099	USD 8.60921
2025-11-24 (Monday)	586	USD 5,045	USD 5,045	0	USD 257	USD 8.60921	USD 8.17065
2025-11-21 (Friday)	586	USD 4,788	USD 4,788	0	USD 205	USD 8.17065	USD 7.82082
2025-11-20 (Thursday)	586	USD 4,583	USD 4,583	0	USD -52	USD 7.82082	USD 7.90956
2025-11-19 (Wednesday)	586	USD 4,635	USD 4,635	0	USD 47	USD 7.90956	USD 7.82935
2025-11-18 (Tuesday)	586	USD 4,588	USD 4,588	0	USD 29	USD 7.82935	USD 7.77986
2025-11-17 (Monday)	586	USD 4,559	USD 4,559	0	USD -147	USD 7.77986	USD 8.03072

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DNA by for IE000T9EOCL3

Show aggregate share trades of DNA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-11 BUY 43 8.760 8.270 8.319 USD 358 9.59
2025-09-25 BUY 85 11.250 11.511 11.485 USD 976 8.82
2025-07-31 BUY 42 13.140 13.626 13.577 USD 570 8.46
2025-06-17 BUY 40 8.550 9.070 9.018 USD 361 7.40
2025-05-14 BUY 152 7.830 8.345 8.294 USD 1,261 7.21
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-11	BUY	43	8.760	8.270	8.319	USD 358	9.59
2025-09-25	BUY	85	11.250	11.511	11.485	USD 976	8.82
2025-07-31	BUY	42	13.140	13.626	13.577	USD 570	8.46
2025-06-17	BUY	40	8.550	9.070	9.018	USD 361	7.40
2025-05-14	BUY	152	7.830	8.345	8.294	USD 1,261	7.21

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DNA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	311,343	0	688,141	45.2%
2025-09-18	237,085	0	571,984	41.4%
2025-09-17	390,999	200	809,164	48.3%
2025-09-16	244,293	0	433,049	56.4%
2025-09-15	238,688	0	607,266	39.3%
2025-09-12	389,687	6,454	759,537	51.3%
2025-09-11	560,578	6,047	1,250,189	44.8%
2025-09-10	466,657	0	912,674	51.1%
2025-09-09	304,200	275	706,987	43.0%
2025-09-08	351,353	36,519	736,113	47.7%
2025-09-05	566,900	32,543	1,066,272	53.2%
2025-09-04	354,008	8,557	645,686	54.8%
2025-09-03	512,959	97,543	941,949	54.5%
2025-09-02	987,971	148,378	1,789,856	55.2%
2025-08-29	671,379	0	1,348,656	49.8%
2025-08-28	595,231	10	1,102,037	54.0%
2025-08-27	492,629	0	862,153	57.1%
2025-08-26	520,624	639	893,417	58.3%
2025-08-25	396,179	0	674,045	58.8%
2025-08-22	579,363	815	1,073,713	54.0%
2025-08-21	337,469	100	579,229	58.3%
2025-08-20	379,849	51,517	759,424	50.0%
2025-08-19	540,731	48,192	893,264	60.5%
2025-08-18	547,409	2,234	895,377	61.1%
2025-08-15	373,483	90	594,502	62.8%
2025-08-14	363,655	667	715,129	50.9%
2025-08-13	562,447	16,044	1,084,196	51.9%
2025-08-12	291,645	0	627,061	46.5%
2025-08-11	313,552	55,570	672,614	46.6%
2025-08-08	442,749	40,378	963,769	45.9%
2025-08-07	439,411	2,264	892,118	49.3%
2025-08-06	365,826	2,846	613,804	59.6%
2025-08-05	583,896	6,739	1,015,182	57.5%
2025-08-04	493,558	61,417	827,603	59.6%
2025-08-01	345,966	30,419	582,737	59.4%
2025-07-31	348,579	608	624,307	55.8%
2025-07-30	428,497	38,545	719,106	59.6%
2025-07-29	337,980	2,726	695,113	48.6%
2025-07-28	270,367	42,479	496,687	54.4%
2025-07-25	345,445	33,133	650,899	53.1%
2025-07-24	733,126	343	1,480,197	49.5%
2025-07-23	435,624	516	1,213,182	35.9%
2025-07-22	964,959	4,757	1,585,120	60.9%
2025-07-21	773,556	753	1,215,604	63.6%
2025-07-18	372,602	1,023	615,488	60.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)
Issuer
Entity holding fund	iShares III Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	EWSA(USD) Euronext Amsterdam